Champions Oncology, Inc. (CSBR)
NASDAQ · Healthcare
Champions Oncology, Inc. Operating Income 2018–2025
Champions Oncology, Inc. annual/quarterly operating income history and growth rate from 2018 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Champions Oncology, Inc. operating income for the quarter ending January 31, 2026 was -276000, a 106.13% decrease year-over-year.
- Champions Oncology, Inc. operating income for the twelve months ending January 31, 2026 was 3.9 M, a 257.06% decrease year-over-year.
- Champions Oncology, Inc. annual operating income for 2025 was 4.6 M, a 161.90% decrease from 2024.
- Champions Oncology, Inc. annual operating income for 2024 was -7.4 M, a 39.95% increase from 2023.
- Champions Oncology, Inc. annual operating income for 2023 was -5.3 M, a 965.90% decrease from 2022.
- Champions Oncology, Inc. annual operating income for 2022 was 607000.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Champions Oncology, Inc. Operating Income — FAQ
Champions Oncology, Inc. (CSBR) operating income over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
What is Champions Oncology, Inc.'s operating income?
Champions Oncology, Inc. (CSBR) reported operating income of $5M for fiscal 2025.
Where can I see CSBR's operating income history?
The chart and table above show Champions Oncology, Inc.'s operating income by year and by quarter, including the growth rate.